Results 231 to 240 of about 113,897 (352)
Primary Small Cell Neuroendocrine Carcinoma of the Sublingual Gland Treated With Definitive Chemoradiotherapy: A Case Report. [PDF]
Tokura TA +10 more
europepmc +1 more source
What's new? Colorectal neuroendocrine carcinoma (CR‐NEC) is a rare digestive neuroendocrine neoplasm that frequently exhibits an adenocarcinoma component. Nonetheless, the underlying biology of CR‐NEC remains poorly understood. This study examined molecular and clinical features and palliative chemotherapy outcomes of metastatic CR‐NEC, with comparison
Siren Morken +20 more
wiley +1 more source
Rectal large cell neuroendocrine carcinoma. [PDF]
Drakos PA +3 more
europepmc +1 more source
Sensitivity and specificity of INSM1 compared with Chromogranin and Synaptophysin in neuroendocrine carcinomas of the head and neck region [PDF]
Phatsorn Amattirat +3 more
openalex +1 more source
What's new? TRIM25 is known for its role in antiviral immunity and association with poor prognosis in various cancers. This study reveals an association between high TRIM25 expression and Merkel cell polyomavirus positivity in Merkel cell carcinoma.
Klaus W. Fagerstedt +6 more
wiley +1 more source
Prognostic and therapeutic roles of specific genotypes through target-gene sequencing on gastroenteropancreatic neuroendocrine carcinoma. [PDF]
Zhang J +14 more
europepmc +1 more source
MON-029 Poorly Differentiated Neuroendocrine Carcinoma of Unknown Primary Origin [PDF]
Mushgan Nassiri +2 more
openalex +1 more source
Chemoresistance in bladder cancer: Macrophage recruitment associated with CXCL1, CXCL5 and CXCL8 expression is characteristic of Gemcitabine/Cisplatin (Gem/Cis) Non‐Responder tumors (right side) while Responder tumors did not show substantial tumor‐stromal crosstalk (left side). All biological icons are attributed to Bioicons: carcinoma, cancerous‐cell‐
Sophie Leypold +11 more
wiley +1 more source
Adebrelimab Combined with Chemotherapy for Esophageal Neuroendocrine Carcinoma: A Case Report. [PDF]
Zhao YG, Zhao T, Ma K, Wang SX.
europepmc +1 more source

